Collegium Infringing OxyContin Patents, Purdue Says
Collegium Pharmaceutical Inc. is infringing two of Purdue Pharma LP's patents tied to the opioid painkiller OxyContin when making and selling its painkiller Xtampza ER, Purdue alleged on Friday in Massachusetts...To view the full article, register now.
Already a subscriber? Click here to view full article